Biological activity of a polypeptide modulator of TRPV1 receptor

被引：6
|
作者：
Dyachenko I.A. [1 ]
Andreev Y.A. [2 ]
Logashina Y.A. [2 ]
Murashev A.N. [1 ]
Grishin E.V. [2 ]
机构：
[1] Pushchino Branch, Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Pushchino, Moscow oblast
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
来源：
Doklady Biological Sciences | 2015年 / 465卷 / 1期
基金：
俄罗斯科学基金会;
关键词：
Capsaicin; Transient Receptor Potential Vanilloid; Analgesic Activity; Cyanogen Bromide; Vanilloid Receptor;
D O I：
10.1134/S0012496615060034
中图分类号：
学科分类号：
摘要：
This paper presents data on the activity of a new APHC2 polypeptide modulator of TRPV1 receptors, which was isolated from the sea anemone Heteractis crispa. It has been shown that APHC2 has an analgesic activity, does not impair normal motor activity, and does not change body temperature of experimental animals, which has a great practical value for design of potent analgesics of a new generation. Further study of the characteristics of binding of the polypeptide to the TRPV1 receptor may show approaches to the development of other antagonists of this receptor that do not influence the body temperature. © 2015, Pleiades Publishing, Ltd.
引用
收藏
页码：279 / 281
页数：2
相关论文
共 50 条
  • [31] Lactate is a potent inhibitor of the capsaicin receptor TRPV1
    Jeanne de la Roche
    Isabella Walther
    Waleria Leonow
    Axel Hage
    Mirjam Eberhardt
    Martin Fischer
    Peter W. Reeh
    Susanne Sauer
    Andreas Leffler
    Scientific Reports, 6
  • [32] The TRPV1 vanilloid receptor: A target for therapeutic intervention
    Breitenbucher, JG
    Chaplan, SR
    Carruthers, NI
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 185 - 198
  • [33] Lactate is a potent inhibitor of the capsaicin receptor TRPV1
    de la Roche, Jeanne
    Walther, Isabella
    Leonow, Waleria
    Hage, Axel
    Eberhardt, Mirjam
    Fischer, Martin
    Reeh, Peter W.
    Sauer, Susanne
    Leffler, Andreas
    SCIENTIFIC REPORTS, 2016, 6
  • [34] Involvement of the TRPV1 receptor and the endocannabinoid system in schizophrenia
    Huang, Junjie
    Huang, Huan
    Liu, Moyin
    Yang, Wanlin
    Wang, Huiling
    BRAIN RESEARCH BULLETIN, 2024, 215
  • [35] Uncoupling proton activation of vanilloid receptor TRPV1
    Ryu, Sujung
    Liu, Beiying
    Yao, Jing
    Fu, Qiang
    Qin, Feng
    JOURNAL OF NEUROSCIENCE, 2007, 27 (47): : 12797 - 12807
  • [36] TRPV1 in colitis: is it a good or a bad receptor? a viewpoint
    Storr, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (08): : 625 - 629
  • [37] Biochemical pharmacology of the vanilloid receptor TRPV1 - An update
    Cortright, DN
    Szallasi, A
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (10): : 1814 - 1819
  • [38] Evodiamine functions as an agonist for the vanilloid receptor TRPV1
    Pearce, LV
    Petukhov, PA
    Szabo, T
    Kedei, N
    Bizik, F
    Kozikowski, AP
    Blumberg, PM
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (16) : 2281 - 2286
  • [39] Evidence of a potentiating role of the TRPV1 receptor in sepsis
    Brain, Susan
    Clark, N.
    Keeble, J.
    INFLAMMATION RESEARCH, 2007, 56 : S398 - S398
  • [40] Design and synthesis of TRPV1 receptor antagonists with anti-inflammatory and analgesic activity
    Quintanar-Audelo, M.
    de Diego, L. Garcia
    Van den Nest, W.
    Carreno, C.
    Ferrer-Montiel, A.
    Albericio, F.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 149 - 149
12345